經導管肺動脈瓣膜市場規模、佔有率和成長分析：按產品類型、手術類型、適應症、年齡層、最終用戶和地區分類－2026-2033年產業預測

2024 年全球經導管肺動脈瓣膜市場價值為 8,000 萬美元，預計到 2033 年將從 2025 年的 8,480 萬美元成長到 1.3516 億美元，預測期（2026-2033 年）的複合年成長率為 6.0%。

全球經導管肺動脈瓣膜市場的主要驅動力是右心室流出道疾病微創治療需求的不斷成長以及創新醫療設備的研發。這些瓣膜專為先天性心臟疾病患者或手術治療選擇有限的患者而設計，與傳統開胸手術相比，它們提供基於導管的治療方法，具有恢復時間更短、風險更低的優勢。諸如「Melody」瓣膜等成熟瓣膜的良好療效促使臨床醫生積極採用這些技術，從而推動了監管部門的批准，並促進了介入性心臟病專科實踐的擴展。隨著中長期研究證實其能夠改善血流動力學並減少併發症，醫院正在加大對結構性心臟疾病計畫的投入，這不僅推動了市場成長，也促使醫療設備產品線不斷發展，以滿足患者多樣化的解剖特徵。擴大的報銷模式和培訓舉措表明，新興市場具有廣泛應用的潛力，透過檢驗臨床療效和透過大規模合作註冊研究實現經濟效益，有望降低成本。

全球經導管肺動脈瓣膜市場的成長要素

經導管肺動脈瓣膜治療的臨床適應症不斷擴大，顯著推動了市場成長，不僅擴大了適用該手術的患者群體，也鼓勵了醫療專業人員採用這項創新治療方法。隨著監管部門的批准和臨床指南的完善，經導管瓣膜的應用範圍不斷擴大，涵蓋了不同的解剖結構和年齡層，醫院也因此被鼓勵加強基礎設施建設，並為醫生提供專門培訓，以便開展這些微創治療。此外，隨著治療模式的不斷發展和保險公司對更新治療方案的調整，經導管肺動脈瓣膜治療在臨床實踐中的應用也將得到更廣泛的認可和推廣。

全球經導管肺動脈瓣市場的限制因素

經導管瓣膜的高昂成本，以及相關手術的專項費用，對全球經導管肺動脈瓣膜市場的成長構成了重大挑戰。這些經濟負擔會阻礙醫院採用這些創新技術，並限制保險公司對常規治療的覆蓋範圍。當採集費用與其他醫療保健優先事項相衝突時，相關項目的開發可能會被延誤，導致患者的治療選擇受限。此外，成本驅動的決策在籌資策略制定中起著至關重要的作用，在預算緊張的情況下，這些治療方法的引入和應用將會進一步延遲。

全球經導管肺動脈瓣膜市場趨勢

全球經導管肺動脈瓣膜市場呈現顯著的成長趨勢，兒童和成人患者群體中的應用均呈上升趨勢。這一轉變主要得益於臨床醫生對該技術的日益熟悉以及多學科心臟醫療團隊的協作，這使得醫生在應對各種解剖結構挑戰時更有信心。創新的器械設計與針對性培訓相結合，能夠有效治療複雜的先天性心臟疾病和功能障礙的外科瓣膜。隨著專科中心和轉診網路的完善，患者越來越傾向於選擇微創治療方法。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢
• 價值鏈分析
• 案例研究
• 技術評估
• 客戶和採購標準分析
• 管道分析
• 疾病流行病學

全球經導管肺動脈瓣膜市場規模：依產品類型分類

• 球囊擴張型閥
• 自膨脹閥

全球經導管肺動脈瓣膜市場規模：依手術類型分類

• 瓣中瓣技術
• 原生RVOT技術

全球經導管肺動脈瓣膜市場規模：依適應症分類

• 肺動脈瓣狹窄
• 肺動脈瓣逆流
• 先天性心臟疾病
• 法洛四部曲

全球經導管肺動脈瓣膜市場規模：依年齡層分類

• 兒童患者
• 成年患者

全球經導管肺動脈瓣膜市場規模：依最終用戶分類

• 醫院
• 心臟導管檢查室
• 專業心臟病中心
• 其他

全球經導管肺動脈瓣膜市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Medtronic plc
• Edwards Lifesciences Corporation
• Abbott Laboratories
• Boston Scientific Corporation
• Meril Life Sciences Pvt. Ltd.
• Venus Medtech（Hangzhou）Inc.
• Peijia Medical Limited
• LivaNova PLC
• MicroPort Scientific Corporation
• Lepu Medical Technology（Beijing）Co., Ltd.
• JC Medical, Inc.
• Foldax, Inc.
• Colibri Heart Valve LLC
• Artivion, Inc.
• Xeltis BV
• JenaValve Technology, Inc.
• CoreMedic GmbH
• InnovHeart Srl
• Balton Sp. z oo
• SMT

結論與建議

Global Transcatheter Pulmonary Valve Market size was valued at USD 80.0 Million in 2024 and is poised to grow from USD 84.8 Million in 2025 to USD 135.16 Million by 2033, growing at a CAGR of 6.0% during the forecast period (2026-2033).

The global transcatheter pulmonary valve market is primarily driven by the rising demand for less invasive therapies for right ventricular outflow tract conditions alongside innovative device developments. These valves cater specifically to patients with congenital heart disease or insufficient surgical options, offering catheter-based solutions with shorter recovery times and reduced risks compared to traditional open-heart surgeries. The positive outcomes of established valves, such as the Melody valve, have encouraged clinicians to adopt these technologies, leading to increased regulatory approvals and the expansion of specialized interventional cardiology practices. As mid- to long-term studies demonstrate improved hemodynamics and fewer complications, hospitals are investing in structural heart programs, fostering market growth and driving the evolution of device offerings to accommodate various patient anatomies. Enhanced reimbursement models and training initiatives signal potential for widespread adoption in emerging markets, paving the way for cost reductions through the validation of clinical efficacy and economic benefits from extensive collaborative registries.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Transcatheter Pulmonary Valve market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Transcatheter Pulmonary Valve Market Segments Analysis

Global transcatheter pulmonary valve market is segmented by product type, procedure type, indication, age group, end user and region. Based on product type, the market is segmented into balloon-expandable valves and self-expandable valves. Based on procedure type, the market is segmented into valve-in-valve procedures and native RVOT procedures. Based on indication, the market is segmented into pulmonary valve stenosis, pulmonary valve regurgitation, congenital heart defects and tetralogy of fallot. Based on age group, the market is segmented into pediatric patients and adult patients. Based on end user, the market is segmented into hospitals, cardiac catheterization laboratories, specialty cardiac centers and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Transcatheter Pulmonary Valve Market

The expansion of clinical indications for transcatheter pulmonary valves significantly propels market growth by widening the patient demographic eligible for these procedures and fostering the adoption of this innovative therapy among healthcare providers. As regulatory endorsements and clinical guidelines facilitate the application of transcatheter valves across diverse anatomical profiles and age ranges, hospitals are prompted to enhance their infrastructure and provide focused training for physicians to deliver these less invasive treatments. Additionally, as payers align with updated treatment protocols due to evolving therapeutic models, this will bolster the broader acceptance and integration of transcatheter pulmonary valve therapies in clinical practice.

Restraints in the Global Transcatheter Pulmonary Valve Market

The high expenses linked to transcatheter valves, coupled with the specialized costs of associated procedures, present a considerable challenge to the growth of the Global Transcatheter Pulmonary Valve market. These financial burdens can inhibit hospitals from adopting these innovative technologies and may restrict payers from granting routine access to them. When the costs of acquiring these valves or necessary infrastructure investments compete with other institutional priorities, the development of related programs can be delayed, resulting in limited treatment options for patients. Additionally, cost-driven decisions play a crucial role in shaping procurement strategies, further slowing the adoption and utilization of these therapies in budget-constrained environments.

Market Trends of the Global Transcatheter Pulmonary Valve Market

The global transcatheter pulmonary valve market is experiencing a notable trend towards expanded utilization in both pediatric and adult populations. This shift is largely propelled by increased clinical familiarity and the collaborative efforts of multidisciplinary heart teams, which enhance physicians' confidence in addressing a wide array of anatomical challenges. Innovative device designs, coupled with targeted training, allow for effective management of complex congenital defects and malfunctioning surgical valves. Patients are increasingly opting for less invasive options with quicker recovery times, supported by improved access through specialized centers and referral networks. Additionally, the focus on demonstrating value through real-world outcomes is shaping reimbursement policies, thereby fostering greater adoption of transcatheter procedures across various healthcare settings.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape
• Value Chain Analysis
• Case Studies
• Technology Assessment
• Customer & Buying Criteria Analysis
• Pipeline Analysis
• Disease Epidemiology

Global Transcatheter Pulmonary Valve Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Balloon-Expandable Valves
• Self-Expandable Valves

Global Transcatheter Pulmonary Valve Market Size by Procedure Type & CAGR (2026-2033)

• Market Overview
• Valve-in-Valve Procedures
• Native RVOT Procedures

Global Transcatheter Pulmonary Valve Market Size by Indication & CAGR (2026-2033)

• Market Overview
• Pulmonary Valve Stenosis
• Pulmonary Valve Regurgitation
• Congenital Heart Defects
• Tetralogy of Fallot

Global Transcatheter Pulmonary Valve Market Size by Age Group & CAGR (2026-2033)

• Market Overview
• Pediatric Patients
• Adult Patients

Global Transcatheter Pulmonary Valve Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Cardiac Catheterization Laboratories
• Specialty Cardiac Centers
• Others

Global Transcatheter Pulmonary Valve Market Size & CAGR (2026-2033)

• North America (Product Type, Procedure Type, Indication, Age Group, End User)
  • US
  • Canada
• Europe (Product Type, Procedure Type, Indication, Age Group, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Procedure Type, Indication, Age Group, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Procedure Type, Indication, Age Group, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Procedure Type, Indication, Age Group, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Medtronic plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edwards Lifesciences Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meril Life Sciences Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Venus Medtech (Hangzhou) Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Peijia Medical Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lepu Medical Technology (Beijing) Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• JC Medical, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Foldax, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Colibri Heart Valve LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Artivion, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Xeltis B.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• JenaValve Technology, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CoreMedic GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• InnovHeart S.r.l.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Balton Sp. z o.o.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SMT
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations